Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A common stock, par value $0.00001 per share
-
Shares outstanding
-
114,401,766
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
105,353,108
-
Shares change
-
+3,614,411
-
Total reported value, excl. options
-
$2,048,895,776
-
Value change
-
+$7,101,276
-
Put/Call ratio
-
66%
-
Number of buys
-
143
-
Number of sells
-
134
-
Price
-
$19.45
Institutional Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) as of Q2 2024
As of 30 Jun 2024 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) had 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 105,353,108 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, ARK Investment Management LLC, BlackRock Inc., Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., MORGAN STANLEY, GENERATION INVESTMENT MANAGEMENT LLP, PRICE T ROWE ASSOCIATES INC /MD/, and BAILLIE GIFFORD & CO.
This table shows 254 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.